ZYG11BL Antibodies

Santa Cruz Biotechnology delivers a wide array of ZYG11BL monoclonal antibodies for research applications. ZYG11BL monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZYG11BL, a member of the ZYG11 family, plays a critical role in regulating cell cycle progression and maintaining genomic stability. The function of ZYG11BL is essential for proper cellular division and has significant implications in cancer research, as alterations in ZYG11BL expression can contribute to tumorigenesis. Research focused on ZYG11BL cellular processes continues to reveal potential therapeutic targets for various diseases. Advanced research techniques utilizing ZYG11BL monoclonal antibodies enable detailed investigation of cellular pathways and mechanisms. Understanding ZYG11BL's role in cell cycle regulation provides valuable insights into disease development and progression. Santa Cruz Biotechnology monoclonal antibodies for ZYG11BL support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.